Finance

Lists
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
4,03 $
-1,71%
(-0,070) 1D
15 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
3,95 $
High
4,15 $
Low
3,91 $
Mkt. cap
19,36 մլն
Avg. vol.
78,61 հզր
Volume
0,00
52-wk high
23,50 $
52-wk low
3,25 $
EPS
-423,73 $
Beta
1,56
Shares outstanding
4,80 մլն
No. of employees
5
Open
3,95 $
High
4,15 $
Low
3,91 $
Mkt. cap
19,36 մլն
Avg. vol.
78,61 հզր
Volume
0,00
52-wk high
23,50 $
52-wk low
3,25 $
EPS
-423,73 $
Beta
1,56
Shares outstanding
4,80 մլն
No. of employees
5
News stories
From web sources and news partners
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current 4,03 $
35,00 $ (+768,49%)
Average
22,25 $ (+452,11%)
Lowest
14,00 $ (+247,39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Initiated
14,00 $
+247,4%
10/12/2026
Thomas Flaten
Lake Street
Buy
Initiated
20,00 $
+396,3%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
20,00 $
+396,3%
09/03/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
35,00 $
+768,5%
08/17/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
12,00 $
+197,8%
06/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
30,00 $
+644,4%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,28 մլն
3,10 մլն
3,43 մլն
3,63 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 մլն
1,42 մլն
1,70 մլն
1,85 մլն
Operating expense
4,02 մլն
4,52 մլն
5,13 մլն
5,47 մլն
Total operating expenses
4,02 մլն
4,52 մլն
5,13 մլն
5,47 մլն
Operating income
-4,02 մլն
-4,52 մլն
-5,13 մլն
-5,47 մլն
Other non operating income
9,49 հզր
364,00
-13,30 հզր
1,58 հզր
EBT including unusual items
-3,95 մլն
-4,35 մլն
-5,00 մլն
-5,37 մլն
EBT excluding unusual items
-3,95 մլն
-4,35 մլն
-5,00 մլն
-5,37 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,95 մլն
-4,35 մլն
-5,00 մլն
-5,37 մլն
Net profit margin
-
-
-
-
Earnings per share
-6,70
-
-1,77
-1,90
Interest and investment income
62,27 հզր
171,70 հզր
146,78 հզր
100,95 հզր
Interest expense
-
-
-
-
Net interest expenses
62,27 հզր
171,70 հզր
146,78 հզր
100,95 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,99 մլն
-4,50 մլն
-5,11 մլն
-5,45 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps